Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments

Young Chul Yoo,Na-Young Kim,Seokyung Shin,Yunil Yang,Ji Hae Jun,Ju Eun Oh,Myoung Hwa Kim

DOI: https://doi.org/10.3390/cancers16071267

2024-03-25

Cancers

Abstract:Lidocaine exerts potential anti-tumor effects on various cancer cell lines, and its intravesical instillation is considered safer than intravenous administration for bladder cancer. However, the mechanisms underlying its anti-tumor effects have not been fully elucidated. Here, we aimed to elucidate the anti-tumor molecular mechanisms of lidocaine in bladder cancer cells and a xenograft model to substantiate the efficacy of its intravesical administration. We investigated the anti-proliferative and autophagyinducing activities of lidocaine in Nara Bladder Tumor No. 2 (NBT-II) rat bladder carcinoma cells using cell viability, flow cytometry, a wound healing assay, and western blotting. We also established a xenograft mouse model of bladder cancer, and cancer growth was examined using in vivo bioluminescence imaging. Lidocaine decreased cell viability, induced G0/G1 phase cell cycle arrest, and inhibited cell migration partially via glycogen synthase kinase (GSK) 3β phosphorylation. Moreover, a combination of lidocaine and SB216763 (a GSK3β inhibitor) suppressed autophagy-related protein expression. Bafilomycin-A1 with lidocaine significantly enhanced microtubule-associated protein 1A/1B-light chain (LC3B) expression; however, it decreased LC3B expression in combination with 3-methyladenine compared to lidocaine alone. In the xenograft mouse model, the bladder cancer volume was reduced by lidocaine. Overall, lidocaine exerts anti-proliferative effects on bladder cancer via an autophagy-inducing mechanism.

oncology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the anti - proliferative effect of lidocaine as an autophagy inducer in bladder cancer and its mechanism. Specifically, through in vitro experiments and experiments on xenograft mouse models, the researchers verified the effectiveness of lidocaine in inhibiting the proliferation of bladder cancer cells through the autophagy pathway. The following are the main research questions of the paper:

1. **Effect of lidocaine on the proliferation of bladder cancer cells**:
- Investigate whether lidocaine can reduce the survival rate of bladder cancer cells (NBT - II cells).
- Explore the effect of lidocaine on the cell cycle, especially whether it can cause cell cycle arrest in the G0/G1 phase.

2. **Effect of lidocaine on cell migration**:
- Through the scratch - wound healing experiment, evaluate the inhibitory effect of lidocaine on the migration ability of bladder cancer cells.

3. **Effect of lidocaine on the expression of autophagy - related proteins**:
- Investigate whether lidocaine can stimulate the phosphorylation of GSK3β and up - regulate the expression of autophagy - related proteins (such as ATG5, ATG7, LC3B and BECN1).

4. **Lidocaine regulates the cell cycle and autophagy through the GSK3β signaling pathway**:
- Use the GSK3β inhibitor SB216763 to verify whether lidocaine affects the expression of cell cycle - and autophagy - related proteins through the GSK3β signaling pathway.

5. **Effect of lidocaine in the xenograft mouse model**:
- By establishing a xenograft mouse model, evaluate the inhibitory effect of lidocaine on bladder tumor growth after transurethral perfusion.

In summary, this paper aims to comprehensively explore the potential application value of lidocaine in the treatment of bladder cancer, especially the molecular mechanism by which it exerts an anti - proliferative effect through the autophagy pathway. These research results provide a theoretical basis for lidocaine as an adjuvant drug for bladder cancer treatment.